Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rickenbacher

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Lancet (London, England)|October 22, 2020
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
The EPMA Journal|June 14, 2018
Novel concept to guide systolic heart failure medication by repeated biomarker testing-results from TIME-CHF in context of predictive, preventive, and personalized medicineNasser Davarzani, Sandra Sanders-van Wijk, Micha T Maeder, et al.
Journal of the American Heart Association|October 9, 2020
Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled TrialGregor Fahrni, Ahmed Farah, Thomas Engstrøm, et al.
Journal of Cardiovascular Development and Disease|March 28, 2023
Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 TrialJulia Seeger, Jochen Wöhrle, Bruno Scheller, et al.
JAMA|January 30, 2009
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trialMatthias Pfisterer, Peter Buser, Hans Rickli, et al.
Clinical Cardiology|March 13, 2018
Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2Nicole Gilgen, Ahmed Farah, Bruno Scheller, et al.
Lancet (London, England)|September 2, 2018
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
Plos One|January 16, 2019
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE IIRaban V Jeger, Matthias Pfisterer, Deborah R Vogt, et al.
Circulation|November 21, 2014
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trialChristoph Kaiser, Soeren Galatius, Raban Jeger, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Lancet (London, England)|October 22, 2020
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
The EPMA Journal|June 14, 2018
Novel concept to guide systolic heart failure medication by repeated biomarker testing-results from TIME-CHF in context of predictive, preventive, and personalized medicineNasser Davarzani, Sandra Sanders-van Wijk, Micha T Maeder, et al.
Journal of the American Heart Association|October 9, 2020
Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled TrialGregor Fahrni, Ahmed Farah, Thomas Engstrøm, et al.
Journal of Cardiovascular Development and Disease|March 28, 2023
Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 TrialJulia Seeger, Jochen Wöhrle, Bruno Scheller, et al.
JAMA|January 30, 2009
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trialMatthias Pfisterer, Peter Buser, Hans Rickli, et al.
Clinical Cardiology|March 13, 2018
Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2Nicole Gilgen, Ahmed Farah, Bruno Scheller, et al.
Lancet (London, England)|September 2, 2018
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
Plos One|January 16, 2019
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE IIRaban V Jeger, Matthias Pfisterer, Deborah R Vogt, et al.
Circulation|November 21, 2014
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trialChristoph Kaiser, Soeren Galatius, Raban Jeger, et al.
Pageof 4